Format

Send to:

Choose Destination
See comment in PubMed Commons below
Neurology. 2001 Oct 23;57(8):1515-7.

Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease.

Author information

  • 1Neurology Service, Albuquerque Veterans Affairs Medical Center, New Mexico, USA.

Abstract

The antioxidant N-acetylcysteine (NAC) or placebo was administered in a double-blind fashion to patients who met National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association criteria for probable AD. Testing for efficacy occurred after 3 and 6 months of treatment. Comparison of interval change favored NAC treatment on nearly every outcome measure, although significant differences were obtained only for a subset of cognitive tasks.

PMID:
11673605
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk